Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Edoxaban (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- Acronyms TACTICAL-HIV
- 14 Sep 2017 Planned End Date changed from 1 May 2018 to 1 sep2018.
- 14 Sep 2017 Planned primary completion date changed from 1 May 2018 to 1 Feb 2018.
- 10 Jun 2017 Biomarkers information updated